Medical advancements in gene targeted therapy and immunotherapy benefits lung cancer patients in terms of survival years, as per the team of researchers at the American hospital, Cleveland Clinic.
Dr. Khaled Hassan, of the Hematology and Medical Oncology Department at Cleveland Clinic, said: "While lung cancer is the most common and deadliest type of cancer, it's not necessarily a death sentence and could be treated as a chronic disease.
Medical innovations in gene targeted therapy and immunotherapy ...
Medical advancements in gene targeted therapy and immunotherapy benefits lung cancer patients in terms of survival years, as per the team of researchers at the American hospital, Cleveland Clinic.
Dr. Khaled Hassan, of the Hematology and Medical Oncology Department at Cleveland Clinic, said: "While lung cancer is the most common and deadliest type of cancer, it's not necessarily a death sentence and could be treated as a chronic disease.
Medical innovations in gene targeted therapy and immunotherapy ...